FUJIFILM Wako Chemicals and Predictive Oncology announced the companies have entered into a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products. Per the terms of the agreement, Predictive Oncology will utilize its novel EndoPrep sample treatment technology together with Fujifilm’s PYROSTAR bacterial endotoxin detection reagent, to detect residual endotoxins more accurately in biopharmaceuticals by eliminating protein interference from the drug product in the detection assay.